Phitech is a TechBio company leading the global shift from DNA-only diagnostics to AI-powered multi-omics, setting a new gold standard for precision medicine in rare diseases and hereditary cancers. Our mission is to make diagnosis faster, more accessible, and more accurate for the 400+ million people with rare diseases and the millions affected by hereditary cancers. Through our flagship platform, G&M, we empower hospitals, laboratories, and pharmaceutical companies with actionable multi-omics insights to improve diagnosis, treatment decisions, and therapeutic development for complex genetic conditions.